The Journal of Organic Chemistry
Note
1.56−1.54 (m, 2H). 13C NMR (100.6 MHz, CDCl3): δ 136.3, 135.4,
128.3, 121.5, 120.1, 119.5, 110.9, 101.7, 56.3, 54.4, 25.6, 24.1. HRMS
(ESI) m/z: calcd for C14H20N3 [M + H]+ 230.1652, found 230.1647.
N-((1H-Indol-2-yl)methyl)cyclohexanamine (2h). Brown oil, 47%,
58.1, 49.9, 14.2. HRMS (ESI) m/z: calcd for C14H19N2O [M + H]+
231.1492, found 231.1487.
2-(1-(4-(3,4-Dichlorophenyl)piperazin-1-yl)ethyl)-1H-indole (2p).
White solid, mp 116.9−117.6 °C, 52%, 97.3 mg. IR (KBr): 3455,
2937, 2825, 1594, 1455, 1247, 1147, 746 cm−1. 1H NMR (400.13 MHz,
CDCl3): δ 8.59 (bs, 1H), 7.62 (d, J = 8.0 Hz, 1H), 7.39 (d, J = 8.0 Hz,
1H), 7.30 (d, J = 8.8 Hz, 1H), 7.24−7.13 (m, 2H), 6.98 (d, J = 3.2 Hz,
1H), 6.75 (dd, J1 = 8.8 Hz, J2 = 3.2 Hz, 1H), 6.41 (s, 1H), 3.95 (q, J = 6.4
Hz, 1H), 3.24−3.14 (m, 4H), 2.75−2.62 (m, 4H), 1.50 (d, J = 6.4 Hz,
3H). 13C NMR (100.6 MHz, CDCl3): δ 150.7, 141.1, 135.8, 132.8,
130.4, 128.5, 122.1, 121.6, 120.3, 119.6, 117.2, 115.3, 110.7, 100.1, 57.7,
49.1, 48.9, 13.8. HRMS (ESI) m/z: calcd for C20H22Cl2N3 [M + H]+
374.1185, found 374.1180.
2-(1-(4-Ethylpiperazin-1-yl)propyl)-1H-indole (2q). Orange oil,
52%, 70.1 mg. IR (neat): 3279, 2928, 1668, 1437, 1119, 723 cm−1. 1H
NMR (400.13 MHz, DMSO): δ 10.86 (bs, 1H), 7.44 (d, J = 7.6 Hz, 1H),
7.33 (t, J = 8.0 Hz, 1H), 7.01 (t, J = 8.4 Hz, 1H), 6.96 (t, J = 7.6 Hz, 1H),
6.21 (s, 1H), 3.86−3.74 (m, 1H), 2.50−2.20 (m, 10H), 1.95−1.75
(m, 2H), 0.93 (t, J = 7.2 Hz, 3H), 0.93 (t, J = 7.2 Hz, 3H), 0.90 (t, J = 7.3
Hz, 3H). 13C NMR (100.6 MHz, DMSO): δ 140.9, 136.6, 132.0, 131.9,
128.6, 128.5, 127.1, 120.8, 119.9, 119.1, 111.4, 99.7, 52.6, 46.0. 13C NMR
(100.6 MHz, CDCl3): δ 138.4, 136.3, 128.1, 120.7, 119.8, 119.0, 111.4,
100.6, 64.7, 63.4, 53.2, 52.0, 24.3, 12.4, 11.7. HRMS (ESI) m/z: calcd for
C17H26N3 [M + H]+ 272.2121, found 272.2111.
1
54.0 mg. IR (neat): 3280, 2920, 1655, 1459, 1382, 790, 735 cm−1. H
NMR (400.13 MHz, CDCl3): δ 9.17 (bs, 1H), 7.55 (d, J = 7.6 Hz, 1H),
7.35 (d, J = 8.0 Hz, 1H), 7.14 (t, J = 7.2 Hz, 1H), 7.08 (t, J = 7.6 Hz, 1H),
6.34 (s, 1H), 4.01 (s, 2H), 2.60−2.48 (m, 1H), 1.95 (d, J = 11.2 Hz, 2H),
1.76−1.70 (m, 2H), 1.66−1.60 (m, 1H), 1.25−1.10 (m, 6H). 13C NMR
(100.6 MHz, CDCl3): δ 137.3, 136.1, 128.4, 121.4, 120.0, 119.5, 110.9,
100.3, 56.2, 43.8, 31.4, 26.0, 24.9. HRMS (ESI) m/z: calcd for C15H21N2
[M + H]+ 229.1699, found 229.1705.
N-((1H-Indol-2-yl)methyl)pentan-1-amine (2i). Brown oil, 40%,
44.0 mg. IR (neat): 3280, 2928, 1668, 1437, 1385, 723 cm−1. 1H NMR
(400.13 MHz, CDCl3): δ 9.02 (bs, 1H), 7.54 (d, J = 6.8 Hz, 1H), 7.32
(d, J = 8.0 Hz, 1H), 7.12 (t, J = 7.2 Hz, 1H), 7.06 (t, J = 8.0 Hz, 1H), 6.32
(s, 1H), 3.95 (s, 2H), 2.63 (t, J = 7.2 Hz, 2H), 2.21 (bs, 1H), 1.34−1.22
(m, 6H), 0.91−0.85 (m, 3H). 13C NMR (100.6 MHz, CDCl3): δ 137.6,
136.1, 128.6, 121.3, 120.0, 119.4, 110.8, 100.2, 60.3, 49.4, 46.9, 29.4,
22.5, 14.0. HRMS (ESI) m/z: calcd for C14H21N2 [M + H]+: 217.1699,
found 217.1693.
N-((1H-Indol-2-yl)methyl)-3-methylbutan-2-amine (2j). Brown oil,
52%, 56.2 mg. IR (neat): 3240, 2961, 1667, 1454, 1384, 784 cm−1. 1H
NMR (400.13 MHz, CDCl3): δ 8.91 (bs, 1H), 7.57 (d, J = 8.0 Hz, 1H),
7.36 (d, J = 8.0 Hz, 1H), 7.17−7.07 (m, 2H), 6.36 (s, 1H), 4.05 (d, J =
14.0 Hz, 1H), 3.95 (d, J = 14.0 Hz, 1H), 2.62−2.53 (m, 1H), 2.28 (bs,
1H), 1.86−1.73 (m, 1H), 1.05 (d, J = 6.4 Hz, 3H), 0.93 (t, J = 6.82 Hz,
6H). 13C NMR (100.6 MHz, CDCl3): δ 138.2, 135.9, 128.5, 121.3,
120.0, 119.5, 110.7, 99.8, 57.7, 44.5, 32.3, 19.3, 17.3, 15.8. HRMS (ESI)
m/z: calcd for C14H21N2 [M + H]+ 217.1699, found 217.1694.
N-((1H-Indol-2-yl)methyl)-1-phenylmethanamine (2k). Brown oil,
50%, 59.1 mg. IR (neat): 3283, 2921, 1667, 1455, 749 cm−1. 1H NMR
(400.13 MHz, DMSO): δ 10.93 (bs, 1H), 7.44 (d, J = 7.2 Hz, 1H),
77.40−7.30 (m, 6H), 6.36 (s, 1H), 7.01 (t, J = 6.8 Hz, 1H), 6.94 (t, J =
7.2 Hz, 1H), 6.27 (s, 1H), 3.82 (s, 2H), 3.72 (s, 2H), 2.00 (bs, 1H). 13C
NMR (100.6 MHz, DMSO): δ 140.9, 136.6, 132.0, 131.9, 128.6, 128.5,
127.1, 120.8, 119.9, 119.1, 111.4, 99.7, 52.6, 46.0. HRMS (ESI) m/z:
calcd for C16H17N2 [M + H]+ 237.1386, found 237.1390.
2-((4-Ethylpiperazin-1-yl)methyl)-5-fluoro-1H-indole (2l). Pale-yel-
low solid, mp 102−104 °C, 58%, 75.8 mg. IR (KBr): 2971, 2813, 1488,
1450, 1174, 771 cm−1. 1H NMR (400.13 MHz, CDCl3): δ 8.73 (bs, 1H),
7.24−7.19 (m, 2H), 6.93−6.87 (m, 1H), 6.34 (s, 1H), 3.67 (s, 2H),
2.56−2.42 (m, 10H), 1.11 (t, J = 7.2 Hz, 3H). 13C NMR (100.6 MHz,
CDCl3): δ 157.8 (d, JCF = 232 Hz), 137.6, 132.6, 128.7 (d, JCF = 10 Hz),
111.1 (d, JCF = 10 Hz), 109.7 (d, JCF = 26 Hz), 105.0 (d, JCF = 23 Hz),
101.7 (d, JCF = 4 Hz), 55.8, 53.2, 52.7, 52.3, 12.0. 19F NMR (376.5 MHz,
CDCl3): δ −125.1. HRMS (ESI) m/z: calcd for C15H21FN3 [M + H]+
262.1714, found 262.1719.
2-((4-Ethylpiperazin-1-yl)(phenyl)methyl)-1H-indole (2r).5 Pale-
yellow solid, mp 106−108 °C, 53%, 84.6 mg. 1H NMR (400.13 MHz,
CDCl3): δ 8.60 (bs, 1H), 7.55 (d, J = 7.6 Hz, 1H), 7.47 (d, J = 7.6 Hz,
2H), 7.37−7.33 (m, 3H), 7.28 (m, 1H), 7.18−7.11 (m, 1H), 7.09−
7.07 (m, 1H), 6.41 (s, 1H), 4.64 (s, 1H), 2.57−2.45 (m, 10H), 1.11
(t, J = 7.2 Hz, 3H). 13C NMR (100.6 MHz, CDCl3): δ 139.1, 139.0,
136.0, 128.5, 128.4, 128.3, 127.6, 121.6, 120.3, 119.6, 110.8, 101.6, 69.2,
53.0, 52.2, 51.0, 11.8.
N-((1H-Indol-2-yl)(phenyl)methyl)butan-1-amine (2s).5 Pale-yel-
low oil, 39%, 54.3 mg. 1H NMR (400.13 MHz, CDCl3): δ 8.62 (bs, 1H),
7.59 (d, J = 8.0 Hz, 1H), 7.41 (d, J = 7.2 Hz, 2H), 7.39−7.32 (m, 4H),
7.21−7.11 (m, 2H), 6.36 (s, 1H), 5.08 (s, 1H), 2.71−2.66 (m, 2H), 1.84
(bs, 1H), 1.61−1.56 (m, 2H), 1.48−1.38 (m, 2H), 0.93 (t, J = 7.6 Hz,
3H). 13C NMR (100.6 MHz, CDCl3): δ 142.4, 141.1, 135.8, 128.7,
128.6, 127.6, 127.3, 121.5, 120.3, 119.6, 110.9, 100.2, 61.6, 47.8, 32.4,
20.5, 14.1.
2-((4-(4-Fluorophenyl)piperazin-1-yl)(phenyl)methyl)-1H-indole
(2t). Pale-yellow oil, 63%, 121.4 mg. IR (neat): 3399, 2830, 1712, 1455,
1240, 1139, 754 cm−1. 1H NMR (400.13 MHz, CDCl3): δ 8.50 (bs, 1H),
7.59 (d, J = 7.6 Hz, 1H), 7.53 (d, J = 7.2 Hz, 2H), 7.43−7.35 (m, 4H),
7.22−7.18 (m, 1H), 7.17−7.12 (m, 1H), 7.03−7.98 (m, 2H), 6.91−6.87
(m, 2H), 6.47 (s, 1H), 4.72 (s, 1H), 3.19−3.16 (m, 4H), 2.72−2.59 (m,
4H). 13C NMR (100.6 MHz, CDCl3): δ 157.2 (d, JCF = 237 Hz), 147.9,
138.9 (d, JCF = 23 Hz), 136.1, 128.7, 128.4, 128.3, 127.8, 126.7, 121.8,
120.4, 119.8, 117.7 (d, JCF = 7.8 Hz), 115.6 (d, JCF = 22 Hz), 110.9,
101.8, 69.2, 51.3, 50.4. 19F NMR (376.5 MHz, CDCl3): δ −124.4.
HRMS (ESI) m/z: calcd for C25H25FN3 [M + H]+ 386.2027, found
386.2021.
1-(5,7-Dimethyl-1H-indol-2-yl)-N,N-diethylethanamine (2u).
Brown wax, 45%, 55.0 mg. IR (KBr): 3455, 2969, 1600, 1457, 1382,
842, 750 cm−1. 1H NMR (400.13 MHz, CDCl3): δ 8.88 (bs, 1H), 7.24
(s, 1H), 6.84 (s, 1H), 6.29 (s, 1H), 4.25 (q, J = 6.4 Hz, 1H), 2.72−2.64
(m, 2H), 2.59−2.54 (m, 2H), 2.52 (s, 3H), 2.45 (s, 3H), 1.45 (d, J = 6.4
Hz, 3H), 1.13 (t, J = 7.2 Hz, 6H). 13C NMR (100.6 MHz, CDCl3): δ
133.7, 128.8, 128.3, 123.7, 119.8, 117.3, 99.8, 53.2, 43.4, 21.4, 16.7, 13.1,
12.0. HRMS (ESI) m/z: calcd for C16H25N2 [M + H]+ 245.2012, found
245.2018.
2-((4-Ethylpiperazin-1-yl)methyl)-5,7-dimethyl-1H-indole (2m).
Brown wax, 69%, 93.6 mg. IR (KBr): 3299, 2937, 2815, 1450, 1010,
1
750 cm−1. H NMR (400.13 MHz, CDCl3): δ 8.56 (bs, 1H), 7.22
(s, 1H), 6.83 (s, 1H), 6.32 (s, 1H), 3.69 (s, 2H), 2.57−2.44 (m, 16H),
1.12 (t, J = 7.2 Hz, 3H). 13C NMR (100.6 MHz, CDCl3): δ 135.0, 134.2,
129.0, 128.0, 123.9, 119.6, 117.5, 102.1, 55.9, 53.1, 52.6, 52.3, 21.4, 16.7,
12.0. HRMS (ESI) m/z: calcd for C17H26N3 [M + H]+ 272.2121, found
272.2115.
N,N-Diethyl-1-(1H-indol-2-yl)ethanamine (2n). Pale-yellow wax,
77%, 83.3 mg. IR (KBr): 3444, 2969, 1455, 1384, 1299, 784, 736 cm−1.
1H NMR (400.13 MHz, CDCl3): δ 8.71 (bs, 1H), 7.57 (d, J = 7.6 Hz,
1H), 7.36 (d, J = 8.0 Hz, 1H), 7.18−7.07 (m, 2H), 6.33 (s, 1H), 4.17
(q, J = 6.4 Hz, 1H), 2.63−2.43 (m, 4H), 1.39 (d, J = 6.4 Hz, 3H), 1.08
(t, J = 7.2 Hz, 6H). 13C NMR (100.6 MHz, CDCl3): δ 143.3, 135.5,
128.9, 121.1, 120.0, 119.3, 110.5, 99.2, 52.8, 43.3, 13.9, 11.4. HRMS
(ESI) m/z: calcd for C14H21N2 [M + H]+ 217.1699, found 217.1693.
4-(1-(1H-Indol-2-yl)ethyl)morpholine (2o). Brown wax, 60%, 69.1
ASSOCIATED CONTENT
■
1
mg. IR (KBr): 3407, 2861, 1455, 1384, 1114, 750 cm−1. H NMR
S
* Supporting Information
(400.13 MHz, CDCl3): δ 8.63 (bs, 1H), 7.60 (d, J = 7.6 Hz, 1H), 7.38 (d,
J = 8.0 Hz, 1H), 7.21−7.10 (m, 2H), 6.38 (s, 1H), 3.86−3.71 (m, 5H),
2.62−2.47 (m, 4H), 1.47 (d, J = 6.8 Hz, 3H). 13C NMR (100.6 MHz,
CDCl3): δ 141.0, 135.8, 128.4, 121.5, 120.2, 119.6, 110.7, 100.2, 67.3,
Copies of 1H and 13C NMR spectra of the products (2a−u). This
material is available free of charge via the Internet at http://pubs.
F
dx.doi.org/10.1021/jo401456x | J. Org. Chem. XXXX, XXX, XXX−XXX